Beyond the conventional attention on amyloid beta and tau pathology, scientists are rapidly pinpointing new pharmacological targets for Alzheimer's illness. These encompass regulating neuroinflammation through blocking glial response, targeting neuronal impairment – particularly associated with NMDA receptor signaling – and exploring the functi